PRTG
ZOM

Post Resch Tallon Group’s Zomedica Corp. ZOM Stock Holding History

Post Resch Tallon Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,000
Closed -$8.85K – 110
2025
Q1 		$8.85K Hold
150,000
– – 0.01% 102
2024
Q4 		$20.7K Buy
+150,000
New +$18.9K 0.02% 104

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
RF
Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

Post Resch Tallon Group's ZOM Position: Q2 2025 in Review

Post Resch Tallon Group sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 150,000 shares — an estimated $8.85K sold.

Post Resch Tallon Group first reported a position in ZOM in Q4 2024 and held it in 2 quarters. The position peaked at $20.7K in Q4 2024. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Post Resch Tallon Group reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Post Resch Tallon Group sold 150,000 Zomedica Corp. shares in Q2 2025, an estimated $8.85K.
  • Post Resch Tallon Group first reported a position in Zomedica Corp. in Q4 2024 and held it in 2 quarters.
  • Post Resch Tallon Group's Zomedica Corp. position peaked at $20.7K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Post Resch Tallon Group's 13F filing for Q2 2025, filed 9 Jul 2025.